Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management
Journal of Clinical Medicine · 22.07.2026 · 15 (14) · 5729
DOI: 10.3390/jcm15145729 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.07.2026. Verfasst von Adil Salihu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bleeding is one of the most common and feared complications after coronary angiography and percutaneous coronary intervention (PCI). It is associated with longer hospital stays, higher mortality, and worse clinical outcomes. As the number of patients at high bleeding risk (HBR) continues to grow, preventing bleeding has become an important part of PCI management. This practical review summarizes current evidence on how to assess bleeding risk and reduce bleeding before, during, and after PCI. Several tools, including the BARC classification, ARC-HBR criteria, PRECISE-DAPT, and DAPT scores, help identify patients who may benefit from tailored treatment. Current strategies include the use of radial access, optimized anticoagulation, appropriate selection of antiplatelet therapy, newer-generation drug-eluting stents, and shorter durations of dual antiplatelet therapy in selected HBR patients. We also discuss the management of patients with atrial fibrillation requiring oral anticoagulation, as well as those with anemia or thrombocytopenia. Although significant progress has been made, several questions remain unanswered, particularly regarding transfusion thresholds, antithrombotic therapy in complex patients, and the best balance between bleeding and ischemic risks. Ongoing clinical trials are expected to provide further evidence and help improve the management of patients undergoing PCI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
- Department of Anesthesiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
ORCID-Profile: Adil Salihu, David Meier
Zitieren
APA
Salihu, A., Meier, D., Mahendiran, T., Zimmerli, A., Buri, J., Klopfenstein, M., Scala, E., & Fournier, S. (2026). Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management. Journal of Clinical Medicine, 15(14), 5729. https://doi.org/10.3390/jcm15145729
Vancouver
Salihu A, Meier D, Mahendiran T, Zimmerli A, Buri J, Klopfenstein M, et al. Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management. Journal of Clinical Medicine. 2026;15(14):5729. doi:10.3390/jcm15145729
BibTeX
@article{Salihu2026,
author = {Salihu, Adil and Meier, David and Mahendiran, Thabo and Zimmerli, Aurelia and Buri, Jeremie and Klopfenstein, Marine and Scala, Emmanuelle and Fournier, Stephane},
title = {Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {14},
pages = {5729},
doi = {10.3390/jcm15145729}
}
EUVIMED